{"timestamp": 1771602947.1745083, "value": {"ticker": "ABCL", "company_name": "AbCellera Biologics Inc.", "short_name": "AbCellera Biologics Inc.", "sector": "Healthcare", "industry": "Biotechnology", "country": "Canada", "market_cap": 912971840, "float_shares": 204326104, "shares_outstanding": 299335048, "short_ratio": 10.08, "short_percent_of_float": 0.21190001, "shares_short": 48902371, "shares_short_prior": 48266214, "insider_percent_held": 0.22969, "institution_percent_held": 0.3786, "total_cash": 495672000, "total_debt": 142218000, "total_revenue": 35325000, "revenue_growth": 0.376, "earnings_growth": 0, "profit_margins": 0.0, "gross_margins": 0.0, "operating_margins": -8.51792, "debt_to_equity": 14.752, "current_ratio": 10.103, "book_value": 3.224, "price_to_book": 0.9460298, "operating_cashflow": -104552000, "free_cashflow": -241470496, "price": 3.05, "52w_high": 6.515, "52w_low": 1.891, "avg_volume": 4225518, "avg_volume_10d": 4931520, "full_time_employees": 596, "audit_risk": 7, "overall_risk": 8}}